Literature DB >> 17486469

Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.

Ronit Haimov-Kochman1, Revital Arbel, Yael Sciaky-Tamir, Amnon Brzezinski, Neri Laufer, Simcha Yagel.   

Abstract

BACKGROUND: The aim of this study was to determine the effectiveness of medical abortions with mifepristone and misoprostol following the approval of medical abortion in Israel.
METHODS: A retrospective review of 377 consecutive medical records at an ambulatory care unit of a university medical centre was performed, screening all women undergoing medical abortion with mifepristone and misoprostol. Transvaginal ultrasonographic study and serum beta hCG measurement were performed 14-20 days after the procedure. The clinical outcome was defined as complete expulsion of intrauterine contents with (failed group) or without (successful group) surgical intervention.
RESULTS: Surgical intervention was performed in 7.4% of patients. Residual products of conception were confirmed in 89%. Older age, previous spontaneous abortions, multigravidity, and earlier follow-up visit were independently associated with unsuccessful medical abortion. Significant differences were found in mean serum beta hCG and mean endometrial thickness in the successful versus failed procedure groups.
CONCLUSIONS: Medical termination of pregnancy with mifepristone and misoprostol is >90% effective. High risk group for failure of the procedure can be characterised. An algorithm of follow up using follow-up visit date, serum beta hCG and sonographic endometrial stripe is suggested to define high risk patients for failed medical abortion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17486469     DOI: 10.1080/00016340701203632

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  4 in total

1.  Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.

Authors:  Mary Gatter; Kelly Cleland; Deborah L Nucatola
Journal:  Contraception       Date:  2015-01-13       Impact factor: 3.375

2.  Diagnostic criteria for retained products of conception-A scoping review.

Authors:  Charlotte C Hamel; Steffi van Wessel; Alasdair Carnegy; Sjors F P J Coppus; Marc P M L Snijders; Justin Clark; Mark H Emanuel
Journal:  Acta Obstet Gynecol Scand       Date:  2021-08-12       Impact factor: 4.544

3.  Serum angiopoietin-2 and β-hCG as predictors of prolonged uterine bleeding after medical abortion in the first trimester.

Authors:  Maofeng Wang; Junqing Chen; Jun Ying; Jiong Yu; Bifei Huang; Zhaoxiang Ren; Xianyu Wang; Qiaoqiao Guo; Yunlai Wang; Liuyi Qiu; Hongsheng Yu; Rugen Wan
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

4.  Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.

Authors:  Ushma D Upadhyay; Nicole E Johns; Sarah L Combellick; Julia E Kohn; Lisa M Keder; Sarah C M Roberts
Journal:  PLoS Med       Date:  2016-08-30       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.